ArticleTechnology in cancer research & treatment
SYNGR2 as a Multifaceted Biomarker in Hepatocellular Carcinoma Linking Prognosis, Immune Microenvironment and Therapeutic Response.
Rong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.